Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IA-GRACE-IgANT: Platform Trial in IgA Nephropathy
NCT06676384Phase 4Recruiting
- Sponsor
- Christian Medical College, Vellore
- Start
- Feb 2025
- Primary completion
- Aug 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone, EPI-EE, mycophenolate mofetil, hydroxychloroquine in IgA nephropathy (IgAN), sponsored by Christian Medical College, Vellore. Started Feb 2025; status: recruiting.
02
Drugs
prednisoloneEPI-EEmycophenolate mofetilhydroxychloroquine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT06676384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06676384.